Ra Capital Management, L.P.
Director at Artiva Biotherapeutics, Inc. (ARTV); Director at Bicara Therapeutics Inc. (BCAX); 10% Owner at Hemab Therapeutics Holdings, Inc. (COAG); Director at Evommune, Inc. (EVMN); 10% Owner at Werewolf Therapeutics, Inc. (HOWL); Director at Parabilis Medicines, Inc. (PBLS); Director at Sionna Therapeutics, Inc. (SION); Director at Vor Biopharma Inc. (VOR); Director at Wave Life Sciences Ltd. (WVE)
Purchase track record
Strong record. Based on 6 purchases with a full 90 days of price history.
92
Avg. 90-day return+28.9%
vs. S&P 500+22.3%
Beat the market67%
Paper profit on buys−$35.8M
Total bought / sold$88.5M / $56.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 21SEC | SIONSionna Therapeutics, Inc. | Sell | 3,415,0113,482,612 held (−50%) | $6.32 | $21.6M | -22.5% |
| Sep 21SEC | SIONSionna Therapeutics, Inc. | Sell | 33,8003,448,812 held (−1%) | $7.46 | $252K | -34.3% |
| Jul 22SEC | PBLSParabilis Medicines, Inc. | Buy | 98,43326,383,526 held (+0%) | $27.13 | $2.7M | +1.3% |
| Jul 22SEC | PBLSParabilis Medicines, Inc. | Buy | 32,98726,416,513 held (+0%) | $27.72 | $914K | -0.9% |
| Jul 22SEC | PBLSParabilis Medicines, Inc. | Buy | 21,69626,438,209 held (+0%) | $27.96 | $607K | -1.7% |
| Jul 22SEC | PBLSParabilis Medicines, Inc. | Buy | 6,50426,444,713 held (+0%) | $29.17 | $190K | -5.8% |
| Jul 22SEC | PBLSParabilis Medicines, Inc. | Buy | 37,72326,482,436 held (+0%) | $30.00 | $1.1M | -8.4% |
| Jul 22SEC | PBLSParabilis Medicines, Inc. | Buy | 47,25026,529,686 held (+0%) | $29.77 | $1.4M | -7.7% |
| Jun 29SEC | ARTVArtiva Biotherapeutics, Inc. | Buy | 31,00016,794,043 held (+0%) | $8.88 | $275K | -21.8% |
| Jun 29SEC | ARTVArtiva Biotherapeutics, Inc. | Buy | 1,87616,795,919 held (+0%) | $8.98 | $17K | -22.7% |
| Jun 22SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 389,2164,268,448 held (−8%) | $0.35 | $136K | +180.0% |
| Jun 22SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 27,695303,719 held (−8%) | $0.35 | $10K | +180.0% |
| Jun 17SEC | COAGHemab Therapeutics Holdings, Inc. | Buy | 6,1466,383,114 held (+0%) | $24.89 | $153K | +27.0% |
| Jun 17SEC | COAGHemab Therapeutics Holdings, Inc. | Buy | 61,5236,444,637 held (+1%) | $24.98 | $1.5M | +26.6% |
| Jun 16SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 159,1194,917,566 held (−3%) | $0.40 | $64K | +145.0% |
| Jun 16SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 11,322349,907 held (−3%) | $0.40 | $5K | +145.0% |
| Jun 16SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 120,2164,797,350 held (−2%) | $0.39 | $47K | +151.3% |
| Jun 16SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 8,554341,353 held (−2%) | $0.39 | $3K | +151.3% |
| Jun 16SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 139,6864,657,664 held (−3%) | $0.37 | $52K | +164.9% |
| Jun 16SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 9,939331,414 held (−3%) | $0.37 | $4K | +164.9% |
| May 21SEC | COAGHemab Therapeutics Holdings, Inc. | Buy | 3,8026,375,972 held (+0%) | $24.97 | $95K | +26.6% |
| May 21SEC | COAGHemab Therapeutics Holdings, Inc. | Buy | 9966,376,968 held (+0%) | $24.94 | $25K | +26.8% |
| May 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 351,5145,885,968 held (−6%) | $0.71 | $250K | +38.0% |
| May 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 25,012418,813 held (−6%) | $0.71 | $18K | +38.0% |
| May 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 81,6785,804,290 held (−1%) | $0.67 | $55K | +46.3% |
| May 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 5,812413,001 held (−1%) | $0.67 | $4K | +46.3% |
| May 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 94,4325,709,858 held (−2%) | $0.64 | $60K | +53.1% |
| May 12SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 6,719406,282 held (−2%) | $0.64 | $4K | +53.1% |
| Apr 21SEC | VORVor Biopharma Inc. | Sell | 458,4112,739,208 held (−14%) | $16.28 | $7.5M | +22.2% |
| Apr 21SEC | VORVor Biopharma Inc. | Sell | 171,9632,567,245 held (−6%) | $15.77 | $2.7M | +26.2% |
| Apr 15SEC | VORVor Biopharma Inc. | Sell | 530,6103,404,998 held (−13%) | $16.15 | $8.6M | +23.2% |
| Apr 15SEC | VORVor Biopharma Inc. | Sell | 153,7353,251,263 held (−5%) | $15.97 | $2.5M | +24.6% |
| Apr 15SEC | VORVor Biopharma Inc. | Sell | 53,6443,197,619 held (−2%) | $16.01 | $859K | +24.3% |
| Mar 30SEC | WVEWave Life Sciences Ltd. | Buy | 4,954,55823,157,567 held (+27%) | $6.06 | $30.0M | -42.9% |
| Mar 30SEC | WVEWave Life Sciences Ltd. | Buy | 351,22423,508,791 held (+2%) | $6.38 | $2.2M | -45.8% |
| Mar 30SEC | WVEWave Life Sciences Ltd. | Buy | 2,495,62326,004,414 held (+11%) | $6.43 | $16.0M | -46.2% |
| Mar 30SEC | WVEWave Life Sciences Ltd. | Buy | 971,09126,975,505 held (+4%) | $6.50 | $6.3M | -46.8% |
| Mar 2SEC | BCAXBicara Therapeutics Inc. | Buy | 300,0004,603,418 held (+7%) | $16.00 | $4.8M | +9.4% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 2,1826,903,443 held (−0%) | $40.20 | $88K | -87.8% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 17,913698,075 held (−3%) | $40.20 | $720K | -87.8% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 11,6262,229,082 held (−1%) | $40.20 | $467K | -87.8% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 13,734195,657 held (−7%) | $40.20 | $552K | -87.8% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 1,7016,901,742 held (−0%) | $41.05 | $70K | -88.1% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 13,964684,111 held (−2%) | $41.05 | $573K | -88.1% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 9,0632,220,019 held (−0%) | $41.05 | $372K | -88.1% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 10,707184,950 held (−5%) | $41.05 | $440K | -88.1% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 536,901,689 held (−0%) | $42.10 | $2K | -88.4% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 433683,678 held (−0%) | $42.10 | $18K | -88.4% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 2802,219,739 held (−0%) | $42.10 | $12K | -88.4% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 331184,619 held (−0%) | $42.10 | $14K | -88.4% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 3326,901,357 held (−0%) | $39.57 | $13K | -87.6% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 2,728680,950 held (−0%) | $39.57 | $108K | -87.6% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 1,7702,217,969 held (−0%) | $39.57 | $70K | -87.6% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 2,092182,527 held (−1%) | $39.57 | $83K | -87.6% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 2,2766,899,081 held (−0%) | $40.01 | $91K | -87.8% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 18,684662,266 held (−3%) | $40.01 | $748K | -87.8% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 12,1262,205,843 held (−1%) | $40.01 | $485K | -87.8% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 14,325168,202 held (−8%) | $40.01 | $573K | -87.8% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 26,899,079 held (−0%) | $40.61 | $81 | -87.9% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 12662,254 held (−0%) | $40.61 | $487 | -87.9% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 82,205,835 held (−0%) | $40.61 | $325 | -87.9% |
| Nov 19SEC | SIONSionna Therapeutics, Inc. | Sell | 9168,193 held (−0%) | $40.61 | $365 | -87.9% |
| Nov 14SEC | WVEWave Life Sciences Ltd. | Buy | 1,00018,203,009 held (+0%) | $6.69 | $7K | -48.3% |
| Nov 12SEC | EVMNEvommune, Inc. | Buy | 1,157,0962,674,425 held (+76%) | $16.00 | $18.5M | -60.9% |
| Nov 12SEC | EVMNEvommune, Inc. | Buy | 92,904784,345 held (+13%) | $16.00 | $1.5M | -60.9% |
| Oct 27SEC | VORVor Biopharma Inc. | Sell | 76,8801,324,346 held (−5%) | $28.01 | $2.2M | -29.0% |
| Oct 27SEC | VORVor Biopharma Inc. | Sell | 53,3451,271,001 held (−4%) | $28.01 | $1.5M | -29.0% |
| Oct 27SEC | VORVor Biopharma Inc. | Sell | 90,9411,180,060 held (−7%) | $28.12 | $2.6M | -29.2% |
- Sell
Director Ra Capital Management, L.P. sold $21.6M of SION at $6.32 — cuts the stake by 50%.
- Buy
Director Ra Capital Management, L.P. bought $2.7M of PBLS at $27.13 — first open-market purchase in our records.
- Buy
Director Ra Capital Management, L.P. bought $275K of ARTV at $8.88 — first open-market purchase in our records.
- Buy
10% Owner Ra Capital Management, L.P. bought $153K of COAG at $24.89 — largest purchase by this insider in our records.
- Buy
10% Owner Ra Capital Management, L.P. bought $1.5M of COAG at $24.98 — largest purchase by this insider in our records.
- Buy
10% Owner Ra Capital Management, L.P. bought $95K of COAG at $24.97 — first open-market purchase in our records.